Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study

John F Keaney1, Izabella Lipinska, Martin G Larson

  • 1Evans Memorial Department of Medicine, Boston University School of Medicine, Boston, MA, USA. john.keaney@umassmed.edu

American Heart Journal
|December 9, 2008
PubMed

Insights

Soluble CD40 ligand (sCD40L) levels in blood are poorly linked to traditional cardiovascular disease risk factors. Genetic factors play a modest role, but more research is needed to understand sCD40L

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Genetics

Background:

  • The CD40 receptor and its ligand (CD40L) influence inflammation and thrombosis, key factors in atherosclerosis.
  • Elevated soluble CD40L (sCD40L) levels are associated with cardiovascular risk in specific patient groups.

Purpose of the Study:

  • To identify predictors of sCD40L concentration in a large, community-based population.
  • To investigate the relationship between sCD40L and established cardiovascular disease (CVD) risk factors.

Main Methods:

  • Serum and plasma sCD40L concentrations were measured in 3,259 participants from the Framingham Offspring Study.
  • Multivariable regression models were used to analyze predictors of sCD40L.

Main Results:

  • Advancing age was the sole consistent inverse correlate of both serum and plasma sCD40L.
  • Clinical covariates explained minimal variability in sCD40L (1.4% serum, 2.7% plasma).
  • Genetic factors accounted for a modest portion of the adjusted variability in sCD40L (12% serum, 14% plasma).

Conclusions:

  • Circulating sCD40L shows weak association with common CVD risk factors.
  • sCD40L exhibits moderate heritability.
  • Longitudinal studies are necessary to determine the predictive value of serum and plasma sCD40L for CVD risk in the general population.
Abstract

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Heritability01:06

Heritability

Heritability is a statistical concept that measures the degree to which genetic differences among individuals contribute to trait variations within a population. It is a fundamental idea in genetics, often prone to misinterpretation. Heritability is expressed as a percentage, reflecting the proportion of variation in a specific trait across a population that can be linked to genetic differences. However, it's important to understand that heritability does not determine how "genetic" a trait is,...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...